Epidermal growth factor-targeted fluorescence is unaffected by standard neoadjuvant therapies in human sarcomas.

Henderson, Eric R; Werth, Paul; Xu, Xiaochun; Jarvis, Lesley A; Paulsen, Keith D; Hoopes, P Jack; Rosenthal, Eben L; Pogue, Brian W; Samkoe, Kimberley S

Henderson, Eric R; Werth, Paul; Xu, Xiaochun; Jarvis, Lesley A; Paulsen, Keith D; Hoopes, P Jack; Rosenthal, Eben L; Pogue, Brian W; Samkoe, Kimberley S.

Afiliación

Henderson ER; Thayer school of Engineering, Dartmouth College, Hanover, NH.
Werth P; Geisel School of Medicine at Dartmouth, Dartmouth College, Hanover, NH.
Xu X; Dartmouth-Hitchcock Medical Center, Lebanon, NH.
Jarvis LA; Geisel School of Medicine at Dartmouth, Dartmouth College, Hanover, NH.
Paulsen KD; Thayer school of Engineering, Dartmouth College, Hanover, NH.
Hoopes PJ; Geisel School of Medicine at Dartmouth, Dartmouth College, Hanover, NH.
Rosenthal EL; Dartmouth-Hitchcock Medical Center, Lebanon, NH.
Pogue BW; Thayer school of Engineering, Dartmouth College, Hanover, NH.
Samkoe KS; Thayer school of Engineering, Dartmouth College, Hanover, NH.

Proc SPIE Int Soc Opt Eng ; 1194302022.

Article en En | MEDLINE | ID: mdl-36052271

Palabras clave

chemotherapy; epidermal growth factor; fluorescence-guided surgery; radiation; sarcoma

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Proc SPIE Int Soc Opt Eng Año: 2022 Tipo del documento: Article